Charles River Laboratories International, Inc. financials
Key figures from Charles River Laboratories International, Inc.'s filings with the U.S. Securities and Exchange Commission: the latest quarter against a year earlier, and the trend across recent quarters and fiscal years.
Latest quarter vs a year earlier
| Metric | Jun 2026 | Jun 2025 | Change |
|---|---|---|---|
| Revenue | $1.0B | $1.0B | -2.7% |
| Net income | -$1M | $52M | -102.8% |
| Free cash flow | $149M | $169M | -12.2% |
| Gross margin | — | — | — |
| Operating margin | 11.9% | 9.7% | +2.2 pts |
| Net margin | -0.1% | 5.1% | -5.2 pts |
Quarterly trend
Fiscal years
| Fiscal year | Revenue | Net income | Net margin | Free cash flow | EPS (diluted) |
|---|---|---|---|---|---|
| FY Dec 2025 | $4.0B | -$144M | -3.6% | $518M | -$2.91 |
| FY Dec 2024 | $4.0B | $22M | 0.5% | $502M | $0.20 |
| FY Dec 2023 | $4.1B | $475M | 11.5% | $365M | $9.22 |
| FY Dec 2022 | $4.0B | $486M | 12.2% | $295M | $9.48 |
| FY Dec 2021 | $3.5B | $391M | 11.0% | $532M | $7.60 |
* Fiscal fourth quarter computed from the annual filing minus the three reported quarters. All figures from company filings with the SEC.